68
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Risperidone monotherapy in manic inpatients: An open label, multicentre trial

, , , , , , , , , & show all
Pages 256-261 | Received 20 Oct 2006, Published online: 12 Jul 2009

References

  • Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229–233
  • Grunze H, Dobmeier M. 2002. Modul Therapie akuter Episoden. In: Deutsche Gesellschaft für Bipolare Störungen e.V. (DGBS e.V.). Weissbuch Bipolare Störungen in Deutschland. Hamburg: CP Verlag. p 57–66.
  • Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53–59
  • Hirschfeld RM, Keck PE, Jr, Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004; 161: 1057–1065
  • Kalkman HO, Loetscher E. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol 2003; 462: 33–40
  • Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: a double-blind, placebo-controlled study of 290 patients. Br J Psychiatry 2005; 187: 229–234
  • Leysen JE, Janssen PM, Megens AA, Schotte A. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 1994; 55(Suppl 5)5–12
  • Licht RW, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264–267
  • Müller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241–247
  • Nguyen LN, Guthrie SK. Risperidone treatment of bipolar mania. Ann Pharmacother 2006; 40: 674–682
  • Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146–1154
  • Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 2005; 15: 75–84
  • Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159–171
  • Suzuki E, Obata M, Yoshida Y, Miyaoka H. Tardive dyskinesia with risperidone and anticholinergics. Am J Psychiatry 2002; 159: 1948
  • Wolfsperger M, Greil W, Rossler W, Grohmann R. 2006. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord in press.
  • Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.